Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Envelope Protein is a recombinant protein expressed in E. coli.
Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Envelope Protein
| Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Envelope Protein |
| Origin | Virus |
| Expression | Recombinant |
| Tested Applications | ELISA, WB, SDS-PAGE |
| Host | E. coli |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Liquid |
| Purity | > 95% (SDS-PAGE) |
| Purification | 0.2 µm filtered. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| UniProt Primary AC | P0DTC4 (UniProt, ExPASy) |
| NCBI Accession | QHD43418.1 |
| Sequence Fragment | Met1-Val75 |
| Sequence | MYSFVSEETG TLIVNSVLLF LAFVVFLLVT LAILTALRLC AYCCNIVNVS LVKPSFYVYS RVKNLNSSRV PDLLV |
| Tag | N-terminal beta-barrel platform (BBP) protein and 6 His tag |
| Buffer | 20 mM Tris-HCl, 200 mM NaCl, pH 8.0. |
| Endotoxin Level | < 0.1 ng/µg (1 IEU/µg) as determined by LAL test. |
| Availability | Shipped within 7-12 working days. |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |